Cargando…

Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma

Natural killer (NK) cells and cytolytic T lymphocytes (CTLs) serve as effectors in the antitumor response. High mobility group nucleosomal binding domain 2 (HMGN2) is a candidate effector molecule involved in CTL and NK cell function. In the current study, recombinant human HMGN2 was isolated and pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	HU, ANKANG, DONG, XIAOQIAN, LIU, XIQIAN, ZHANG, PING, ZHANG, YONGHONG, SU, NING, CHEN, QIANMING, FENG, YUN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861564/ https://www.ncbi.nlm.nih.gov/pubmed/24348831 http://dx.doi.org/10.3892/ol.2013.1665

Ejemplares similares

Nucleosome structural changes induced by binding of non-histone chromosomal proteins HMGN1 and HMGN2()
por: Shimahara, Hideto, et al.
Publicado: (2013)

HMGN2, a new anti-tumor effector molecule of CD8(+) T cells
por: Su, Lin, et al.
Publicado: (2014)

Chromatin De-Compaction By The Nucleosomal Binding Protein HMGN5 Impairs Nuclear Sturdiness
por: Furusawa, Takashi, et al.
Publicado: (2015)

Lysine succinylation on non-histone chromosomal protein HMG-17 (HMGN2) regulates nucleosomal DNA accessibility by disrupting the HMGN2–nucleosome association
por: Jing, Yihang, et al.
Publicado: (2021)

Epigenetic regulation of white adipose tissue plasticity and energy metabolism by nucleosome binding HMGN proteins
por: Nanduri, Ravikanth, et al.
Publicado: (2022)

H3K27ac nucleosomes facilitate HMGN localization at regulatory sites to modulate chromatin binding of transcription factors
por: Zhang, Shaofei, et al.
Publicado: (2022)

Spatial and Temporal Expression of High-Mobility-Group Nucleosome-Binding (HMGN) Genes in Brain Areas Associated with Cognition in Individuals with Down Syndrome
por: Rodríguez-Ortiz, Alejandra, et al.
Publicado: (2021)

Human HMGN1 and HMGN2 are not required for transcription-coupled DNA repair
por: Apelt, Katja, et al.
Publicado: (2020)

HMGN1 Modulates Nucleosome Occupancy and DNase I Hypersensitivity at the CpG Island Promoters of Embryonic Stem Cells
por: Deng, Tao, et al.
Publicado: (2013)

Binding of HMGN proteins to cell specific enhancers stabilizes cell identity
por: He, Bing, et al.
Publicado: (2018)

Biological Functions of HMGN Chromosomal Proteins
por: Nanduri, Ravikanth, et al.
Publicado: (2020)

Effects of HMGN variants on the cellular transcription profile
por: Rochman, Mark, et al.
Publicado: (2011)

Metabolomics Reveals a Role for the Chromatin-Binding Protein HMGN5 in Glutathione Metabolism
por: Ciappio, Eric D., et al.
Publicado: (2014)

Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells
por: Fan, Bo, et al.
Publicado: (2019)

Plasmodium falciparum Nucleosomes Exhibit Reduced Stability and Lost Sequence Dependent Nucleosome Positioning
por: Silberhorn, Elisabeth, et al.
Publicado: (2016)

The In Vitro and In Vivo Antitumor Effects of Clotrimazole on Oral Squamous Cell Carcinoma
por: Wang, Juan, et al.
Publicado: (2014)

Exogenous HMGN2 inhibits the migration and invasion of osteosarcoma cell lines
por: Xu, Enjie, et al.
Publicado: (2020)

A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo
por: Zou, Jianling, et al.
Publicado: (2018)

Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis
por: Xie, Ping, et al.
Publicado: (2011)

SIRT6 exhibits nucleosome-dependent deacetylase activity
por: Gil, Reuven, et al.
Publicado: (2013)

Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma
por: Lin, Lin, et al.
Publicado: (2016)

Functional genomics of HMGN3a and SMARCAL1 in early mammalian embryogenesis
por: Uzun, Alper, et al.
Publicado: (2009)

Multiple epigenetic factors co-localize with HMGN proteins in A-compartment chromatin
por: He, Bing, et al.
Publicado: (2022)

Functional compensation among HMGN variants modulates the DNase I hypersensitive sites at enhancers
por: Deng, Tao, et al.
Publicado: (2015)

HMGN2 regulates non‐tuberculous mycobacteria survival via modulation of M1 macrophage polarization
por: Wang, Xinyuan, et al.
Publicado: (2019)

Stereochemical control of nucleosome targeting by platinum-intercalator antitumor agents
por: Chua, Eugene Y.D., et al.
Publicado: (2015)

miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5
por: Wei, Xin, et al.
Publicado: (2018)

Oncolytic viro-chemotherapy exhibits antitumor effect in laryngeal squamous cell carcinoma cells and mouse xenografts
por: Wang, Yigang, et al.
Publicado: (2019)

In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma
por: Jia, Lihua, et al.
Publicado: (2017)

Characterization of Dnmt1 Binding and DNA Methylation on Nucleosomes and Nucleosomal Arrays
por: Schrader, Anna, et al.
Publicado: (2015)

Comprehensive nucleosome interactome screen establishes fundamental principles of nucleosome binding
por: Skrajna, Aleksandra, et al.
Publicado: (2020)

HMGN1 and 2 remodel core and linker histone tail domains within chromatin
por: Murphy, Kevin J., et al.
Publicado: (2017)

HMGN2 represses gene transcription via interaction with transcription factors Lef-1 and Pitx2 during amelogenesis
por: Eliason, Steven, et al.
Publicado: (2022)

HMGN proteins modulate chromatin regulatory sites and gene expression during activation of naïve B cells
por: Zhang, Shaofei, et al.
Publicado: (2016)

HMGN1 enhances CRISPR-directed dual-function A-to-G and C-to-G base editing
por: Yang, Chao, et al.
Publicado: (2023)

Inflammation promotes oral squamous carcinoma immune evasion via induced programmed death ligand-1 surface expression
por: LU, WANLU, et al.
Publicado: (2013)

miR-488 Inhibits Cell Growth and Metastasis in Renal Cell Carcinoma by Targeting HMGN5 [Retraction]
Publicado: (2021)

Interplay between H1 and HMGN epigenetically regulates OLIG1&2 expression and oligodendrocyte differentiation
por: Deng, Tao, et al.
Publicado: (2017)

Involvement of potential pathways in malignant transformation from Oral Leukoplakia to Oral Squamous Cell Carcinoma revealed by proteomic analysis
por: Wang, Zhi, et al.
Publicado: (2009)

HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways
por: Alam, Md Masud, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8l86q6vtksf8eqbokv5n74pej9